{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:56:47Z","timestamp":1758049007954,"version":"3.44.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bbrc.2024.149611","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T11:21:08Z","timestamp":1707391268000},"page":"149611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Network-based drug repositioning of linagliptin as a potential agent for uterine fibroids targeting transforming growth factor-beta mediated fibrosis"],"prefix":"10.1016","volume":"703","author":[{"given":"Anusha Shreenidhi","family":"Bhat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amritha","family":"Chakkittukandiyil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santhosh Kumar","family":"Muthu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satvik","family":"Kotha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8736-6418","authenticated-orcid":false,"given":"Sudharsan","family":"Muruganandham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3382-4316","authenticated-orcid":false,"given":"Kalirajan","family":"Rajagopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saravanan","family":"Jayaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8104-9046","authenticated-orcid":false,"given":"Ram","family":"Kothandan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6434-6583","authenticated-orcid":false,"given":"Divakar","family":"Selvaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbrc.2024.149611_bib1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/molehr\/gat083","article-title":"Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues","volume":"20","author":"Holdsworth-Carson","year":"2014","journal-title":"Mol. Hum. Reprod."},{"issue":"5","key":"10.1016\/j.bbrc.2024.149611_bib2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1530\/REP-16-0216","article-title":"Differences in the cellular composition of small versus large uterine fibroids","volume":"152","author":"Holdsworth-Carson","year":"2016","journal-title":"Reproduction"},{"issue":"1","key":"10.1016\/j.bbrc.2024.149611_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.13102","article-title":"Epidemiology and management of uterine fibroids","volume":"149","author":"Giuliani","year":"2020","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"3","key":"10.1016\/j.bbrc.2024.149611_bib4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajog.2013.08.008","article-title":"The health disparities of uterine fibroid tumors for African American women: a public health issue","volume":"210","author":"Eltoukhi","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.bbrc.2024.149611_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/humupd\/dmw023","article-title":"Uterine fibroid management: from the present to the future","volume":"22","author":"Donnez","year":"2016","journal-title":"Hum. Reprod. Update"},{"issue":"2","key":"10.1016\/j.bbrc.2024.149611_bib6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5468\/ogs.2018.61.2.192","article-title":"Working group of society of uterine leiomyoma. Current medical treatment of uterine fibroids","volume":"61","author":"Sohn","year":"2018","journal-title":"Obstet. Gynecol. Sci."},{"issue":"5","key":"10.1016\/j.bbrc.2024.149611_bib7","first-page":"720","article-title":"Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group","volume":"77","author":"Friedman","year":"1991","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.bbrc.2024.149611_bib8","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1210\/clinem\/dgab081","article-title":"Use of ulipristal acetate and risk of liver disease: a nationwide cohort study","volume":"106","author":"Yoon","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bbrc.2024.149611_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/humupd\/dmx032","article-title":"Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics","volume":"24","author":"Islam","year":"2018","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.bbrc.2024.149611_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/783289","article-title":"The extracellular matrix contributes to mechanotransduction in uterine fibroids","volume":"2014","author":"Leppert","year":"2014","journal-title":"Obstet. Gynecol. Int."},{"key":"10.1016\/j.bbrc.2024.149611_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.633180","article-title":"Understanding the impact of uterine fibroids on human Endometrium function","volume":"9","author":"Navarro","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"11","key":"10.1016\/j.bbrc.2024.149611_bib12","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.3390\/ijms18112435","article-title":"Role of transforming growth factor \u03b2 in uterine fibroid biology","volume":"18","author":"Ciebiera","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2024.149611_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jcp.25879","article-title":"TGF\u03b2 signaling and the control of myofibroblast differentiation: implications for chronic inflammatory disorders","volume":"233","author":"Carthy","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.bbrc.2024.149611_bib14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s43032-022-01064-0","article-title":"Importance of fibrosis in the pathogenesis of uterine leiomyoma and the promising anti-fibrotic effects of dipeptidyl peptidase-4 and fibroblast activation protein inhibitors in the treatment of uterine leiomyoma","volume":"30","author":"Bhat","year":"2023","journal-title":"Reprod. Sci."},{"issue":"51","key":"10.1016\/j.bbrc.2024.149611_bib15","doi-asserted-by":"crossref","first-page":"36505","DOI":"10.1074\/jbc.274.51.36505","article-title":"Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts","volume":"274","author":"Park","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.bbrc.2024.149611_bib16","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/eurheartj\/ehq519","article-title":"Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata","volume":"32","author":"Brokopp","year":"2011","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.bbrc.2024.149611_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088772","article-title":"Fibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activation","volume":"9","author":"Chung","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbrc.2024.149611_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40364-020-00245-w","article-title":"Biomarkers for cancer-associated fibroblasts","volume":"8","author":"Han","year":"2020","journal-title":"Biomark. Res."},{"issue":"3","key":"10.1016\/j.bbrc.2024.149611_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.yexmp.2009.09.001","article-title":"TGF-beta induces fibroblast activation protein expression; fibroblast activation protein expression increases the proliferation, adhesion, and migration of HO-8910PM [corrected]","volume":"87","author":"Chen","year":"2009","journal-title":"Exp. Mol. Pathol."},{"issue":"12","key":"10.1016\/j.bbrc.2024.149611_bib20","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1172\/JCI38988","article-title":"Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice","volume":"119","author":"Santos","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.bbrc.2024.149611_bib21","doi-asserted-by":"crossref","first-page":"e1155","DOI":"10.1038\/cddis.2014.122","article-title":"Downregulation of FAP suppresses cell proliferation and metastasis through PTEN\/PI3K\/AKT and Ras-ERK signaling in oral squamous cell carcinoma","volume":"5","author":"Wang","year":"2014","journal-title":"Cell Death Dis."},{"issue":"146","key":"10.1016\/j.bbrc.2024.149611_bib22","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0057-2017","article-title":"Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis","volume":"26","author":"Lancaster","year":"2017","journal-title":"Eur. Respir. Rev."},{"issue":"4","key":"10.1016\/j.bbrc.2024.149611_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1165\/rcmb.2019-0328TR","article-title":"Pirfenidone: molecular mechanisms and potential clinical applications in lung disease","volume":"62","author":"Ruwanpura","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"8","key":"10.1016\/j.bbrc.2024.149611_bib24","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.drudis.2015.05.001","article-title":"Drug repositioning and repurposing: terminology and definitions in literature","volume":"20","author":"Langedijk","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"D1","key":"10.1016\/j.bbrc.2024.149611_bib25","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","article-title":"Stitch 5: augmenting protein-chemical interaction networks with tissue and affinity data","volume":"44","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.bbrc.2024.149611_bib26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1021\/ml300410d","article-title":"Selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold","volume":"4","author":"Jansen","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"issue":"20","key":"10.1016\/j.bbrc.2024.149611_bib27","doi-asserted-by":"crossref","first-page":"19441","DOI":"10.1074\/jbc.C500092200","article-title":"Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein \u03b1","volume":"280","author":"Aertgeerts","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbrc.2024.149611_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/cei.12757","article-title":"Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and\/or structure homologue (DASH) proteins","volume":"184","author":"Wagner","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"9","key":"10.1016\/j.bbrc.2024.149611_bib29","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1021\/bi00124a019","article-title":"Identification of the active site residues in dipeptidyl peptidase IV by affinity labeling and site-directed mutagenesis","volume":"31","author":"Ogata","year":"1992","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.bbrc.2024.149611_bib30","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bbrc.2024.149611_bib31","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/07391102.2020.1715261","article-title":"Syringaresinol as a novel androgen receptor antagonist against wild and mutant androgen receptors for the treatment of castration-resistant prostate cancer: molecular docking, in-vitro and molecular dynamics study","volume":"39","author":"Selvaraj","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"9","key":"10.1016\/j.bbrc.2024.149611_bib32","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20187627","article-title":"Establishment of a rat model for uterine leiomyomas based on Western and traditional Chinese medicine theories","volume":"51","author":"Zhao","year":"2018","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.bbrc.2024.149611_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118101","article-title":"TRIM9 overexpression promotes uterine leiomyoma cell proliferation and inhibits cell apoptosis via NF-\u03baB signaling pathway","volume":"257","author":"Yang","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2024.149611_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12939-020-01327-9","article-title":"Assessing burden, risk factors, and perceived impact of uterine fibroids on women's lives in rural Haiti: implications for advancing a health equity agenda, a mixed methods study","volume":"20","author":"Millien","year":"2021","journal-title":"Int. J. Equity Health"},{"key":"10.1016\/j.bbrc.2024.149611_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.phrs.2015.06.012","article-title":"From pathogenesis to therapy\u2013perspective on treatment strategies in fibrotic diseases","volume":"100","author":"Ramming","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bbrc.2024.149611_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.41058","article-title":"Dipeptidylpeptidase 4 as a marker of activated fibroblasts and a potential target for the treatment of fibrosis in systemic sclerosis","volume":"72","author":"Soare","year":"2020","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.bbrc.2024.149611_bib37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/path.4104","article-title":"The myofibroblast matrix: implications for tissue repair and fibrosis","volume":"229","author":"Klingberg","year":"2013","journal-title":"J. Pathol."},{"issue":"10","key":"10.1016\/j.bbrc.2024.149611_bib38","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/1078-0432.CCR-06-1811","article-title":"Tumor-specific efficacy of transforming growth factor-\u03b2RI inhibition in Eker rats","volume":"13","author":"Laping","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbrc.2024.149611_bib39","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","article-title":"The role of fibroblast activation protein in health and malignancy","volume":"39","author":"Fitzgerald","year":"2020","journal-title":"Cancer Metastasis Rev."},{"issue":"6","key":"10.1016\/j.bbrc.2024.149611_bib40","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1111\/jcmm.15020","article-title":"microRNA\u201030a attenuates TGF\u2010\u03b21\u2013induced activation of pulmonary fibroblast cell by targeting FAP\u2010\u03b1","volume":"24","author":"Wu","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bbrc.2024.149611_bib41","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.922644","article-title":"Sitagliptin inhibits extracellular matrix accumulation and proliferation in lung fibroblasts","volume":"26","author":"Liu","year":"2020","journal-title":"Med Sci Monit"},{"issue":"1","key":"10.1016\/j.bbrc.2024.149611_bib42","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1080\/0886022X.2017.1279553","article-title":"Renoprotective effects of a dipeptidyl peptidase 4 inhibitor in a mouse model of progressive renal fibrosis","volume":"39","author":"Uchida","year":"2017","journal-title":"Ren. Fail."},{"issue":"2","key":"10.1016\/j.bbrc.2024.149611_bib43","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1110\/ps.03460604","article-title":"Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation","volume":"13","author":"Aertgeerts","year":"2004","journal-title":"Protein Sci."},{"issue":"11","key":"10.1016\/j.bbrc.2024.149611_bib44","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1039\/C4MD00167B","article-title":"Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffold","volume":"5","author":"Jansen","year":"2014","journal-title":"Med. Chem. Comm."},{"issue":"11","key":"10.1016\/j.bbrc.2024.149611_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166275","article-title":"Comparative binding analysis of dipeptidyl peptidase IV (DPP-4) with antidiabetic drugs\u2013an ab initio fragment molecular orbital study","volume":"11","author":"Arulmozhiraja","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbrc.2024.149611_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.repbio.2021.100501","article-title":"Therapeutic modality of induced uterine leiomyoma with shock waves in rats: the uterine blood flow, circulating ovarian hormones and histopathological findings","volume":"21","author":"Mamoon","year":"2021","journal-title":"Reprod. Biol."},{"issue":"12","key":"10.1016\/j.bbrc.2024.149611_bib47","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005058","article-title":"Extracellular matrix degradation and remodeling in development and disease","volume":"3","author":"Lu","year":"2011","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"3","key":"10.1016\/j.bbrc.2024.149611_bib48","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.trsl.2013.11.008","article-title":"Estrogen-mediated activation of fibroblasts and its effects on the fibroid cell proliferation","volume":"163","author":"Luo","year":"2014","journal-title":"Transl. Res."},{"issue":"10","key":"10.1016\/j.bbrc.2024.149611_bib49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/iovs.64.10.2","article-title":"DPP-4 inhibitors attenuate fibrosis after glaucoma filtering surgery by suppressing the TGF-\u03b2\/smad signaling pathway","volume":"64","author":"Yoshida","year":"2023","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2024.149611_bib50","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1038\/s41467-021-26495-2","article-title":"The serine proteases dipeptidyl-peptidase 4 and urokinase are key molecules in human and mouse scar formation","volume":"12","author":"Vorstandlechner","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.149611_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.552818","article-title":"Soluble dipeptidyl peptidase-4 induces fibroblast activation through proteinase-activated receptor-2","volume":"11","author":"Lee","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.149611_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107503","article-title":"Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions","volume":"209","author":"Shao","year":"2020","journal-title":"Pharmacol. Ther."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24001463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24001463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:39:11Z","timestamp":1757767151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24001463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":52,"alternative-id":["S0006291X24001463"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.149611","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Network-based drug repositioning of linagliptin as a potential agent for uterine fibroids targeting transforming growth factor-beta mediated fibrosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.149611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"149611"}}